2506 — Xunfei Healthcare Technology Co Balance Sheet
0.000.00%
- HK$8.41bn
- HK$8.20bn
- CNY733.98m
Annual balance sheet for Xunfei Healthcare Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 434 | 248 | 168 | 677 | 365 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 249 | 338 | 590 | 850 | 1,184 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 727 | 652 | 853 | 1,681 | 1,682 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 11.3 | 11.3 | 15.6 | 21.7 | 25.4 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,014 | 1,030 | 1,238 | 2,090 | 2,312 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 488 | 603 | 671 | 1,000 | 1,189 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 587 | 688 | 739 | 1,150 | 1,416 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 427 | 341 | 499 | 940 | 897 |
| Total Liabilities & Shareholders' Equity | 1,014 | 1,030 | 1,238 | 2,090 | 2,312 |
| Total Common Shares Outstanding |